As of 2026-04-28, the Intrinsic Value of Medicenna Therapeutics Corp (MDNA.TO) is -1.02 CAD. This MDNA.TO valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.65 CAD, the upside of Medicenna Therapeutics Corp is -257.48%.
Based on its market price of 0.65 CAD and our intrinsic valuation, Medicenna Therapeutics Corp (MDNA.TO) is overvalued by 257.48%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -1.02 - -1.02 | -1.02 | -257.48% |
| P/E | (0.03) - (0.21) | (0.03) | -104.7% |
| DDM - Stable | (1.33) - (4.76) | (3.04) | -568.1% |
| DDM - Multi | (0.36) - (1.05) | (0.54) | -183.7% |
| Market Cap (mil) | 41.24 |
| Beta | 2.22 |
| Outstanding shares (mil) | 63.44 |
| Enterprise Value (mil) | 30.76 |
| Market risk premium | 5.10% |
| Cost of Equity | 11.33% |
| Cost of Debt | 5.00% |
| WACC | 11.30% |